raloxifene hydrochloride has been researched along with gemcitabine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allerheiligen, SR; Callies, S; Forgue, ST; Ni, L; Peck, R; Sinha, V; Zhang, L | 1 |
Celia, C; Cosco, D; Costante, G; Filetti, S; Fresta, M; Iannone, M; Paolino, D; Puxeddu, E; Racanicchi, L; Russo, D; Trapasso, E | 1 |
2 other study(ies) available for raloxifene hydrochloride and gemcitabine
Article | Year |
---|---|
Model-based drug development: the road to quantitative pharmacology.
Topics: Adult; Aged; Algorithms; Antimetabolites, Antineoplastic; Biomarkers; Clinical Trials as Topic; Computer Simulation; Decision Making; Deoxycytidine; Dose-Response Relationship, Drug; Drug Industry; Female; Gemcitabine; Humans; Male; Middle Aged; Models, Biological; Osteocalcin; Osteoporosis, Postmenopausal; Pharmacology; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome | 2006 |
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Deoxycytidine; Floxuridine; Gemcitabine; Half-Life; Liposomes; Mice; Mice, Inbred NOD; Mice, SCID; Polyethylene Glycols; Raloxifene Hydrochloride; Tissue Distribution; Unilamellar Liposomes | 2010 |